Virologic failure after 48 weeks of raltegravir-based regimen in low HIV-1 incidence setting:

BackgroundWith the advent of next generation integrase strand transfer inhibitors, the rates of virologic failure in treated subjects are expected to decrease. In this study, we analyzed the mutati...